Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
13.93
-0.66 (-4.52%)
Mar 31, 2025, 1:17 PM EDT - Market open
Centessa Pharmaceuticals Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$25.63
Upside
+83.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $38 | Buy | Initiates | $38 | +172.79% | Mar 31, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +101.01% | Mar 26, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $27 | Buy | Initiates | $27 | +93.83% | Mar 7, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Feb 10, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jan 7, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $24 → $28 | Strong Buy | Maintains | $24 → $28 | +101.01% | Nov 15, 2024 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $11 → $26 | Hold → Buy | Upgrades | $11 → $26 | +86.65% | Sep 19, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +136.90% | Sep 19, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $20 → $35 | Buy | Maintains | $20 → $35 | +151.26% | Sep 16, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $20 → $24 | Strong Buy | Maintains | $20 → $24 | +72.29% | Sep 11, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $13 → $19 | Strong Buy | Maintains | $13 → $19 | +36.40% | Sep 11, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $15 → $20 | Buy | Maintains | $15 → $20 | +43.58% | Sep 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $14 | Buy | Reiterates | $14 | +0.50% | Aug 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $14 | Buy | Initiates | $14 | +0.50% | Jul 18, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $11 | Hold | Maintains | $8 → $11 | -21.03% | Jun 21, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $15 | Buy | Maintains | $15 | +7.68% | Apr 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.